[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fPkJdfDIHkqYDmkMuWfAYb6p1-GrkJija3jQtC2PD-5g":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":32,"rows":39},"University of Nevada, Reno",[4],28,false,6,1,11441,0,25,[14,17,19,21,23,25,27,29],{"name":15,"count":16},"Anxiety",2,{"name":18,"count":16},"Specific Phobia",{"name":20,"count":16},"Depression, Anxiety",{"name":22,"count":16},"Anxiety Disorders",{"name":24,"count":9},"Social Anxiety",{"name":26,"count":9},"HIV",{"name":28,"count":9},"Burnout, Healthcare Workers",{"name":30,"count":9},"Wellness Program",[],[33,34,35,36,37,38],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[40,66,91,117],{"intervention":41,"totalTrials":9,"cells":42},"Linagliptin",{"EARLY_PHASE1":43,"PHASE1":45,"PHASE2":47,"PHASE3":49,"PHASE4":51,"NA":64},{"trials":44,"activeCount":11},[],{"trials":46,"activeCount":11},[],{"trials":48,"activeCount":11},[],{"trials":50,"activeCount":11},[],{"trials":52,"activeCount":11},[53],{"nctId":54,"briefTitle":55,"status":56,"phases":57,"primaryCompletion":58,"completion":58,"start":59,"enrollment":60,"conditions":61,"interventions":63},"NCT02442817","Linagliptin and Mesenchymal Stem Cells: A Pilot Study","COMPLETED",[37],"2018-03-02","2015-03-02",10,[62],"Schizophrenia",[41],{"trials":65,"activeCount":11},[],{"intervention":67,"totalTrials":9,"cells":68},"Oral Vancomycin",{"EARLY_PHASE1":69,"PHASE1":71,"PHASE2":73,"PHASE3":75,"PHASE4":77,"NA":89},{"trials":70,"activeCount":11},[],{"trials":72,"activeCount":11},[],{"trials":74,"activeCount":11},[],{"trials":76,"activeCount":11},[],{"trials":78,"activeCount":11},[79],{"nctId":80,"briefTitle":81,"status":56,"phases":82,"primaryCompletion":83,"completion":83,"start":84,"enrollment":85,"conditions":86,"interventions":88},"NCT03466502","Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics",[37],"2022-02-17","2018-03-08",104,[87],"Clostridium Difficile Infection",[67],{"trials":90,"activeCount":11},[],{"intervention":92,"totalTrials":9,"cells":93},"Simethicone Solution",{"EARLY_PHASE1":94,"PHASE1":96,"PHASE2":98,"PHASE3":100,"PHASE4":113,"NA":115},{"trials":95,"activeCount":11},[],{"trials":97,"activeCount":11},[],{"trials":99,"activeCount":11},[],{"trials":101,"activeCount":11},[102],{"nctId":103,"briefTitle":104,"status":56,"phases":105,"primaryCompletion":106,"completion":106,"start":107,"enrollment":108,"conditions":109,"interventions":111},"NCT03410524","Evaluation of Oral Simethicone With Low Volume Polyethylene Glycol Bowel Preparation During Colonoscopy",[36],"2018-10-31","2018-01-09",250,[110],"Colonoscopy",[92,112],"Water",{"trials":114,"activeCount":11},[],{"trials":116,"activeCount":11},[],{"intervention":112,"totalTrials":9,"cells":118},{"EARLY_PHASE1":119,"PHASE1":121,"PHASE2":123,"PHASE3":125,"PHASE4":131,"NA":133},{"trials":120,"activeCount":11},[],{"trials":122,"activeCount":11},[],{"trials":124,"activeCount":11},[],{"trials":126,"activeCount":11},[127],{"nctId":103,"briefTitle":104,"status":56,"phases":128,"primaryCompletion":106,"completion":106,"start":107,"enrollment":108,"conditions":129,"interventions":130},[36],[110],[92,112],{"trials":132,"activeCount":11},[],{"trials":134,"activeCount":11},[]]